aspidin bb has been researched along with quercetin 3-o-methyl ether in 1 studies
| Studies (aspidin bb) | Trials (aspidin bb) | Recent Studies (post-2010) (aspidin bb) | Studies (quercetin 3-o-methyl ether) | Trials (quercetin 3-o-methyl ether) | Recent Studies (post-2010) (quercetin 3-o-methyl ether) |
|---|---|---|---|---|---|
| 10 | 0 | 7 | 47 | 0 | 23 |
| Protein | Taxonomy | aspidin bb (IC50) | quercetin 3-o-methyl ether (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 1.904 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 1.904 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 30.34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatadi, S; Gour, J; Nanduri, S | 1 |
1 review(s) available for aspidin bb and quercetin 3-o-methyl ether
| Article | Year |
|---|---|
Natural product derived promising anti-MRSA drug leads: A review.
Topics: Animals; Anti-Bacterial Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2019 |